Post Graduate Institute of Medical Education and Research, Chandigarh: Pulmonary Aspergillosis trials

The registry lists 11 Pulmonary Aspergillosis studies with Post Graduate Institute of Medical Education and Research, Chandigarh as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 7Phase 3 10Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary AspergillosisRecruitingNCT06174922Phase 3
• A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary AspergillosisCompletedNCT04824417Phase 3
• Deflazacort Vs. Prednisolone in Acute-stage ABPAActive, not recruitingNCT04227483Phase 2/3
• Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPACompletedNCT03920527Phase 3
• A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating AsthmaCompletedNCT03133299Phase 2/3
• A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary AspergillosisCompletedNCT02440009Phase 2/3
• A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary AspergillosisCompletedNCT01857479Phase 2/3
• Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary AspergillosisCompletedNCT01621321Phase 2/3
• Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary AspergillosisCompletedNCT01321827Phase 2/3
• Efficacy Of Itraconazole In Chronic Cavitary Pulmonary AspergillosisCompletedNCT01259336Phase 4
• Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary AspergillosisCompletedNCT00974766Phase 2/3